GLP1R and type 2 diabetes mellitus: Although GLP-1 RA drugs are associated with cardiovascular benefits in people with and without type 2 diabetes [57,58], recent meta-analyses also report increased resting heart rate and higher treatment discontinuation rates due to adverse effects [57].